Abbott US diabetes device sales up 27% amid largely positive Q1
Abbott has posted strong revenue for its diabetes devices in Q1, despite overall sales for the company narrowly missing Wall Street expectations. The medtech giant posted an increase in year-over-year overall revenue of 4%, giving total takings of $10.36bn …